Studiet var et åbent, randomiseret, aktivt kontrolleret, klinisk fase II studie som undersøgte Avastin i kombination med 5- FU/ FA som førstelinje behandling af metastatisk kolorektalkræft.
This was a phase II randomised, active-controlled, open-labelled clinical trial investigating Avastin in combination with 5-FU/ FA as first-line treatment of metastatic colorectal cancer.